Oncology

Latest News

FDA Approval Sought for Mirdametinib in NF1-PN | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA approval sought for mirdametinib in NF1-PN

March 4th 2024

SpringWorks Therapeutics has initiated a new drug application for mirdametinib in neurofibromatosis type 1-associated plexiform neurofibromas.

FDA approves eflornithine for pediatric patients with high-risk neuroblastoma | Image Credit: © calin - © calin - stock.adobe.com.
FDA approves eflornithine for pediatric patients with high-risk neuroblastoma

December 14th 2023

FDA expands nivolumab approval to treat adolescents with stage IIB/C melanoma | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA expands nivolumab approval to treat adolescents with Stage IIB/C melanoma

October 16th 2023

For children with leukemia or lymphoma, what does a pediatrician need to know?
For children with leukemia or lymphoma, what does a pediatrician need to know?

July 26th 2023

Ultrasound radiomics for predicting extrathyroidal extension in children
Ultrasound radiomics for predicting extrathyroidal extension in children

February 28th 2023

Video Interviews
Latest CME Events & Activities

FAQs in Peanut Allergy: Exploring Unanswered Questions Following Allergy Meeting Updates

View More

Earn CME Credits While Advancing Your Expertise in Internal Medicine

April 18-19, 2024

Register Now!

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

Medical Crossfire®: Onco-Nursing Best Practices for Managing AEs Related to CAR T-Cell Therapy from Treatment Center to Community

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines

View More

(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?

View More

Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)

View More

Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Cases and Conversations™: Evidence-Based Approaches to Management of CKD in Your Patients with T2DM

September 25, 2024

Register Now!

Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency

View More

3rd Annual International Congress on Pediatric Oncology

October 25, 2024

View More

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Medical Crossfire®: How Has the Nurse’s Role Evolved in the Management of Pediatric Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas?

View More

2nd Annual International Congress on Pediatric Oncology

View More

Advances In™ Rare Genetic Forms of Obesity: Emerging Therapeutic Targets

View More

Patient, Provider, and Caregiver Connection™: Developing Strategies to Improve Patient Access to Care for Thalassemia - Understanding Patient Challenges and the Role of Innovative Treatment

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer

View More

Comprehensive Approaches to Creating Successful Sickle Cell Management Plans Across Patients’ Lifespans

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients

View More

Medical Crossfire®: Bridging Expert Guidance and Evidence-Based Recommendations in the Treatment of AYA and Adult ALL

View More

Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today

View More

Experts Address the Hottest Topics in AML: Considerations on FLT3, IDH1/2, TP53, Maintenance, Novel Combinations and Beyond!

View More

More News

© 2024 MJH Life Sciences

All rights reserved.